載入...
Mixed Response to Ipilimumab in a Melanoma Patient with Brain Metastases: Case Report and Review of the Literature
Management of patients suffering from metastatic malignant melanoma and brain metastasis remains challenging in routine clinical practice. The inhibitory anti-CTLA-4 antibody ipilimumab has recently been approved as second-line therapeutic option for melanoma patients. Increasing evidence suggests d...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
S. Karger AG
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3656679/ https://ncbi.nlm.nih.gov/pubmed/23687494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000351125 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|